title: Evidence of tubular hypoxia in the early phase in the remnant kidney model.
abstract: The remnant kidney model is a mainstay in the study of progressive renal disease. The earliest changes in this model result from glomerular hemodynamic alterations. Given that progressive renal disease is the result of subsequent interstitial damage initiated by undetermined pathogenic factors, the authors investigated the role of hypoxia as a pathogenic factor in tubulointerstitial damage after renal ablation in rats. Cortical tissue hypoxia in the early phase (4 and 7 d) in remnant kidney rats, sham-operated rats, and animals treated with the angiotensin II receptor blocker (ARB) olmesartan (10 mg/kg per d) was assessed by uptake of a hypoxic probe, pimonidazole, expression of HIF-1alpha, and by increased transcription of hypoxia-responsive genes. Physiologic perfusion status of the postglomerular peritubular capillary network was evaluated by lectin perfusion and Hoechst 33342 diffusion techniques. Results showed that the number of hypoxic tubules was markedly increased 4 and 7 d after nephron loss. These findings antedated any histologic evidence of tubulointerstitial damage. The hypoxic state persisted until interstitial damage developed. These results were confirmed using HIF-1alpha immunoprecipitation and increase of hypoxia-responsive genes. Pathologic studies of the vasculature demonstrated significant functional changes that generated a hypoxic milieu. ARB treatment prevented vascular changes and ameliorated tubular hypoxia. These results suggest that the initial tubulointerstitial hypoxia in remnant kidney model plays a pathogenic role in the subsequent development of tubulointerstitial injury. The initial hypoxia in this model was dependent on activation of the renin-angiotensin system and hemodynamic alterations after nephron loss.
authors.affiliation: Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan.
authors.forename: Krissanapong
authors.initials: K
authors.lastname: Manotham
authors.forename: Tetsuhiro
authors.initials: T
authors.lastname: Tanaka
authors.forename: Makiko
authors.initials: M
authors.lastname: Matsumoto
authors.forename: Takamoto
authors.initials: T
authors.lastname: Ohse
authors.forename: Toshio
authors.initials: T
authors.lastname: Miyata
authors.forename: Reiko
authors.initials: R
authors.lastname: Inagi
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Kurokawa
authors.forename: Toshiro
authors.initials: T
authors.lastname: Fujita
authors.forename: Masaomi
authors.initials: M
authors.lastname: Nangaku
mesh_terms: D000818:Animals; D001562:Benzimidazoles; D002196:Capillaries / Q000502:physiology; D002455:Cell Division; D004195:Disease Models, Animal; D042783:Endothelial Cells / Q000473:pathology; D005456:Fluorescent Dyes; D000860:Hypoxia / Q000473:pathology* / Q000503:physiopathology*; D007674:Kidney Diseases / Q000473:pathology* / Q000503:physiopathology*; D007684:Kidney Tubules / Q000098:blood supply / Q000473:pathology* / Q000503:physiopathology; D008297:Male; D009392:Nephrectomy; D051381:Rats; D017207:Rats, Sprague-Dawley; D012079:Renal Circulation
chemical_list: D001562:Benzimidazoles; D005456:Fluorescent Dyes; C017807:bisbenzimide ethoxide trihydrochloride